STVN - Stevanato Group SpA logo

Stevanato Group SpA

STVN
Revenue grew 100% of years5Y
Compare STVN Hold

Stevanato Group S.p.A. designs and produces drug containment solutions like pre-fillable syringes and vials, along with drug delivery systems and diagnostic solutions for biopharma and healthcare sectors globally. It serves pharmaceutical and life sciences companies.

⚕️ Healthcare NYSE Listed 2021 € EUR
$1,000 invested 5 years ago →$796today

Score Overview

1 Year
Score
Net Growth-0.06%
Net TrendShrank
Net Income Consistency—
Rev Growth7.24%
Rev TrendGrew
Revenue Consistency—
5 Years
Score6.0
Net Growth-0.09%
Net Trend60%
Net Income Consistency—
Rev Growth44.80%
Rev TrendEvery year
Revenue Consistency—
All Time
Score
Net Growth-0.09%
Net Trend60%
Net Income Consistency
Rev Growth44.80%
Rev TrendEvery year
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Stevanato Group SpA has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. STVN does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 19.50—
1 Year2025-10-22
$ 25.80-24.41%
5 Years2021-10-22
$ 24.50-20.41%
All Time2021-07-16
$ 19.380.63%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in EUR

Year
TTM€ 1.22B€ 134M
2025€ 1.13B€ 134M€ 132M
2024€ 1.10B€ 117M€ 98M
2023€ 1.08B€ 145M€ 70M
2022€ 983M€ 142M€ 256M
IPO2021€ 843M€ 134M€ 438M
STVN - Stevanato Group SpA logo

Stevanato Group SpA fundamental performance

Between 2021 and 2025, revenue grew from € 843M to € 1.13B and net income declined from € 134M to € 134M. Revenue increased in 100% of the years measured; net income in 60%.

Stevanato Group SpA currently holds a 5-year HDB Score of 6.0 out of 10. How the HDB Score is calculated.

Membership

Explore STVN with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies